AC Immune Correlations

ACIU Stock  USD 3.36  0.04  1.18%   
The current 90-days correlation between AC Immune and Eliem Therapeutics is 0.19 (i.e., Average diversification). The correlation of AC Immune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

AC Immune Correlation With Market

Average diversification

The correlation between AC Immune and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AC Immune and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AC Immune. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

Moving against ACIU Stock

  0.65PLRX Pliant TherapeuticsPairCorr
  0.52LPTX Leap TherapeuticsPairCorr
  0.49PMVP Pmv PharmaceuticalsPairCorr
  0.43PHVS Pharvaris BVPairCorr
  0.34ESLAW Estrella ImmunopharmaPairCorr
  0.49ACRV Acrivon Therapeutics,PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BDTXRGNX
BDTXELYM
PEPGELYM
RGNXELYM
IVVDANEB
ANEBPEPG
  
High negative correlations   
BDTXABEO
ABEORGNX
PEPGPMVP
ELYMPMVP
BDTXPHVS
ABEOELYM

Risk-Adjusted Indicators

There is a big difference between ACIU Stock performing well and AC Immune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AC Immune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PMVP  1.61  0.03 (0.03) 0.25  2.00 
 3.75 
 13.98 
ELYM  3.92 (1.02) 0.00 (1.30) 0.00 
 6.21 
 34.87 
MNOV  5.09  1.33  0.17 (0.44) 4.27 
 14.50 
 61.30 
PHVS  2.94  0.25  0.09  0.29  2.99 
 7.76 
 21.41 
PEPG  3.14 (1.20) 0.00 (0.59) 0.00 
 4.78 
 26.81 
RGNX  3.33 (0.53) 0.00 (0.12) 0.00 
 5.72 
 32.22 
ANEB  5.13 (0.11) 0.00  0.21  0.00 
 8.61 
 76.00 
IVVD  4.97 (1.32) 0.00 (0.28) 0.00 
 12.75 
 28.68 
ABEO  1.94  0.01 (0.01) 0.14  2.32 
 3.79 
 12.28 
BDTX  3.49 (1.65) 0.00 (0.63) 0.00 
 5.47 
 19.51 

AC Immune Corporate Management

Julian SnowVP DevelopmentProfile
Nuno MDChief OfficerProfile
Christopher RobertsInterim FinProfile
Sonia PoliHead ScienceProfile
Piergiorgio DonatiChief OfficerProfile
Pr MDChief OfficerProfile
Joshua DrummHead RelationsProfile